Compare Baker Hughes Co (BKR) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Baker Hughes Co vs GeneDx Holdings Corp — how do they compare? Baker Hughes Co trades at $64.74 (market cap $64.34B), while GeneDx Holdings Corp trades at $82 (market cap $2.44B). The key difference: Baker Hughes Co is far larger — about 26.4× GeneDx Holdings Corp's market cap, and Baker Hughes Co pays a 1.42% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| BKR | WGS | |
|---|---|---|
Market Cap | $64.34B | $2.44B |
Sector | Energy | Technology |
52-Week High | $69.67 | $167.51 |
52-Week Low | $42.51 | $34.51 |
Enterprise Value | $64.86B | $2.48B |
Dividend Yield | 1.42% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Baker Hughes Co
Baker Hughes is a global leader in oilfield services and oilfield equipment, with particularly strong presences in the artificial lift, specialty chemicals, and completions markets. The other half of its business focuses on industrial power generation, process solutions, and industrial asset management, with high exposure to the liquid natural gas market specifically, as well as broader industrials end markets.
Read more on BKR →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
